The magnitude of proliferation reduction correlated with mTOR inhibition but not with intratumoural concentrations of rapamycin. Phosphorylation of the S6 ribosomal protein, a downstream effector ...

Rapamycin is used to prevent graft rejection in transplant recipients based on its ability to suppress T-cell proliferation. The drug blocks the activity of a protein known as mammalian target of ...